Director
DIN: 08481004
Pawan Kumar Suri is currently associated with 2 companies in various capacities such as Managing Director and Director. They serve as a Director at PHARMALEX INDIA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08481004.Pawan Kumar Suri has previously been associated with 2 companies in roles such as Additional Director.Pawan Kumar Suri is currently involved in 2 different roles. Their most recent position is with CUNESOFT INDIA PRIVATE LIMITED as a Director. The first company Pawan Kumar Suri was appointed to as a director was PHARMALEX INDIA PRIVATE LIMITED. Pawan Kumar Suri is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Pawan Kumar Suri is currently associated with 2 companies in various capacities such as Managing Director and Director. They serve as a Director at PHARMALEX INDIA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08481004.Pawan Kumar Suri has previously been associated with 2 companies in roles such as Additional Director.Pawan Kumar Suri is currently involved in 2 different roles. Their most recent position is with CUNESOFT INDIA PRIVATE LIMITED as a Director. The first company Pawan Kumar Suri was appointed to as a director was PHARMALEX INDIA PRIVATE LIMITED. Pawan Kumar Suri is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (0)
Past Companies (2)
1y 5m 9 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| PHARMALEX INDIA PRIVATE LIMITED | Managing Director | 01-Jul-2019 |
| CUNESOFT INDIA PRIVATE LIMITED | Director | 29-Sep-2023 |